Research area
Drug Delivery & Nanomedicine
Therapeutic delivery systems, targeting and medical nanoparticles across diseases.
-
Evidence date ·How tiny lipid carriers change where brain-tumor treatments act
Review or Meta-AnalysisA July 2023 review explains how lipid carriers route drugs or RNA toward brain tumors or immune cells, and what early trials can show.
-
Evidence date ·Can magnetic particles help immune cells reach and attack tumors?
Review or Meta-AnalysisMagnetic particles can carry immune drugs, trigger iron-driven stress and generate heat under a field. A 2022 review weighs promise against dose risks.
-
Evidence date ·How tiny drug carriers could connect cell aging research with Alzheimer’s care
Review or Meta-AnalysisA 2022 review explains how nanoparticle carriers move anti-aging drugs toward the brain and separates brain exposure, pathology, and memory evidence.
-
Evidence date ·How changing a drug carrier could matter for cancer immunotherapy
Review or Meta-AnalysisA 2022 review examines modifiable chitosan carriers for cancer immunotherapy. Its abstract does not establish benefits for patients.
-
Evidence date ·How tiny gold particles could carry treatment and help immune cells recognize breast cancer
Review or Meta-AnalysisA 2022 mini review explains how tiny gold particles carry immune-active treatments or turn tumor damage into immune signals, without proving patient protection.
-
Evidence date ·A chitosan fragment study links tumor immune signaling with gemcitabine
Peer-Reviewed PaperA 2022 study links chitosan sugar fragments to lower PD-L1, an immune-suppressing protein, and stronger tumor responses with chemotherapy. Human benefit is unproven.
-
Evidence date ·How a porous scaffold could link tumor injury to immune action
Review or Meta-AnalysisTracked over timeA 2026 review explains how porous frameworks alter tumor chemistry, trigger immune signals in mice, and face limits in activation, breakdown, and production.
-
Evidence date ·How a copper-containing scaffold links light-driven chemistry with immune treatment
Peer-Reviewed PaperTracked over timeA copper-containing molecular scaffold uses light and copper chemistry to damage cancer cells and support immune activation alongside anti-PD-1 treatment.
-
Evidence date ·Can a porous material help the immune system act beyond one tumor?
Peer-Reviewed PaperTracked over timeResearchers linked inactive molecules into porous frameworks, then tested COF-609 with anti-CD47 in mice, where more than 95% survived to day 110.
-
Evidence date ·How a gel helped an RNA treatment last longer in injured rat discs
Peer-Reviewed PaperA 2021 rat study tested a self-healing water-rich gel that carried gene-silencing RNA, slowed disc deterioration, and left human treatment unproven.